Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 123,601 | 117,715 | 105,654 | 103,056 | 101,728 |
| Cost of Goods | 1,645 | 1,574 | 1,386 | 1,480 | 1,339 |
| Gross Profit | 121,956 | 116,141 | 104,268 | 101,576 | 100,389 |
| Operating Expenses | 91,424 | 87,132 | 89,801 | 79,557 | 68,794 |
| Operating Income | 31,177 | 29,583 | 14,853 | 22,499 | 31,934 |
| Other Income | 5,208 | 3,347 | 3,581 | 1,777 | 1,070 |
| Pre-tax Income | 36,385 | 32,930 | 18,434 | 24,276 | 33,004 |
| Income Tax | 5,007 | 5,402 | 2,555 | 7,675 | -1,604 |
| Net Income Continuous | 31,378 | 27,528 | 15,879 | 16,601 | 34,608 |
| Net Income | $31,378 | $27,528 | $15,879 | $16,601 | $34,608 |
| EPS Basic Total Ops | 0.31 | 0.27 | 0.15 | 0.15 | 0.32 |
| EPS Basic Continuous Ops | 0.31 | 0.27 | 0.15 | 0.15 | 0.32 |
| EPS Diluted Total Ops | 0.28 | 0.25 | 0.14 | 0.13 | 0.30 |
| EPS Diluted Continuous Ops | 0.28 | 0.25 | 0.14 | 0.14 | 0.30 |
| EBITDA(a) | $31,466 | $32,028 | $14,209 | $25,106 | $30,816 |